Professional Documents
Culture Documents
Background-—Studies have shown that long-term exposure to air pollution such as fine particulate matter (≤2.5 lm in
aerodynamic diameter [PM2.5]) increases the risk of all-cause and cardiovascular mortality. To date, however, there are limited data
on the impact of air pollution on specific cardiovascular diseases. This study aimed to evaluate cardiovascular effects of long-term
exposure to air pollution among residents of Seoul, Korea.
Methods and Results-—Healthy participants with no previous history of cardiovascular disease were evaluated between 2007 and
2013. Exposure to air pollutants was estimated by linking the location of outdoor monitors to the ZIP code of each participant’s
residence. Crude and adjusted analyses were performed using Cox regression models to evaluate the risk for composite
cardiovascular events including cardiovascular mortality, acute myocardial infarction, congestive heart failure, and stroke. A total of
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
136 094 participants were followed for a median of 7.0 years (900 845 person-years). The risk of major cardiovascular events
increased with higher mean concentrations of PM2.5 in a linear relationship, with a hazard ratio of 1.36 (95% confidence interval,
1.29–1.43) per 1 lg/m3 PM2.5. Other pollutants including PM2.5–10 of CO, SO2, and NO2, but not O3, were significantly associated
with increased risk of cardiovascular events. The burden from air pollution was comparable to that from hypertension and diabetes
mellitus.
Conclusions-—This large-scale population-based study demonstrated that long-term exposure to air pollution including PM2.5
increases the risk of major cardiovascular disease and mortality. Air pollution should be considered an important modifiable
environmental cardiovascular risk factor. ( J Am Heart Assoc. 2017;6:e007170. DOI: 10.1161/JAHA.117.007170.)
Key Words: air pollution • cardiovascular disease risk factors • epidemiology • particulate matter
ORIGINAL RESEARCH
Table 1. Baseline Profiles of Study Population
Clinical Perspective
Characteristics Values
What Is New?
Total number of participants 136 094
• This study showed that every 1-lg/m3 increase of long-term Age, y 42.0514.83 (136 094)*
exposure to fine particulate matter ≤2.5 lm in aerodynamic
<45 y 58.2 (79 245/136 094)
diameter was associated with a 36% increased risk of
cardiovascular events among healthy participants with no 45–54 y 21.3 (29 006/136 094)
history cardiovascular diseases who resided in Seoul, Korea. 55–64 y 11.8 (16 174/136 094)
• The effects were consistent for all cardiovascular events ≥65 y 8.6 (11 669/136 094)
including cardiovascular mortality, acute myocardial infarc-
Male sex 49.1 (66 851/136 094)
tion, congestive heart failure, and stroke.
Income quintiles
What Are the Clinical Implications? Upper 32.4 (44 127/136 094)
• Long-term exposure to ambient air pollutants is a major risk Upper middle 21.1 (28 712/136 094)
factor for cardiovascular diseases. Middle 17.7 (24 100/136 094)
• Ambient air pollution needs to be considered as a public Lower middle 15.4 (20 957/136 094)
health issue, and measures to control the level of air
Lower 11.3 (15 407/136 094)
pollution are required to reduce the burden of cardiovascu-
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
ORIGINAL RESEARCH
Air Pollution Exposure Estimates codes I63 to 64 and I60 to 62, respectively. Composite
cardiovascular events were defined as a composite of
We obtained information on daily air pollution levels provided
cardiovascular death, AMI, CHF, and stroke.
by the Korean Ministry of Environment website (http://www.a
irkorea.or.kr). Air pollutants including PM2.5, particles with a
diameter <10 lm (PM10), carbon monoxide (CO), sulfur Statistical Analyses
dioxide (SO2), nitrogen dioxide (NO2), and ozone (O3) were
Baseline characteristics were shown as meanSD or propor-
collected from 27 monitoring stations in Seoul. We measured
tions. Cox proportional hazards models were used to assess
PM2.5 by mass concentration, PM10 by the b-ray absorption
the association between air pollution exposure and study
method, CO by the nondispersive infrared method, SO2 by
outcomes. Hazard ratios (HRs) and 95% confidence intervals
pulse ultraviolet fluorescence, NO2 by chemiluminescence,
were calculated for the risk of time-dependent variables.
and O3 by ultraviolet photometry.
Multiple statistical models were constructed to adjust for
Each individual’s exposure to air pollutants was determined
potential confounding factors. We evaluated unadjusted
by linking the location of the monitoring stations to the ZIP
models, age and sex-adjusted models, and multivariable
code of his or her residence. The long-term average concen-
models. Multivariable-adjusted model 1 was controlled for
trations of the air pollutants were estimated by daily averages
age, sex, socioeconomic status, hypertension, diabetes mel-
from the date of study enrollment to the occurrence of study
litus, dyslipidemia, chronic renal failure, end-stage renal
end points. Data points that were highly discrepant with other
diseases, ischemic heart disease, peripheral arterial disease,
observations were excluded from the analysis.
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
A B
40
Estimated value
(μg/m3)
35
30
25
20
15
10
Figure 1. The concentrations of PM2.5 in Seoul, 2007–2013. (A) Maps of average PM2.5 concentrations, and (B) yearly concentrations of PM2.5
at each monitor. PM2.5 indicates fine particulate matter ≤2.5 lm in aerodynamic diameter.
ORIGINAL RESEARCH
Results frequently observed cardiovascular event, followed by CHF,
AMI, hemorrhagic stroke, and cardiovascular mortality.
Study Participants and Exposure to Air Pollution A concentration-response curve with the penalized spline
A total of 136 094 residents of Seoul were included in this Cox regression model suggested that long-term exposure to
study. As shown in Table 1, the study participants were PM2.5, PM2.5–10, CO, SO2, and NO2 was associated with an
representative of the general population. The mean age was increased occurrence of composite cardiovascular events
42 years, and 49.1% were men. The proportions of hyperten- (cardiovascular mortality, AMI, CHF, and stroke; Figure 2).
sion, diabetes mellitus, dyslipidemia, and active smoking were The risk of composite cardiovascular events was elevated by
9.8%, 3.1%, 7.5%, and 24.2%, respectively. The mean body 36% for a 1-lg/m3 increase of PM2.5 (Table 2, Figure 3). All
mass index was 23.5 kg/m2, and blood pressure was 122/ study outcomes including mortality, CHF, AMI, and stroke were
76 mm Hg. significantly associated with long-term exposure to PM2.5. In
Figure 1 shows the average concentrations of PM2.5 within numerical terms, the increase in risk was highest for CHF and
Seoul, which significantly decreased during the study period. lowest for hemorrhagic stroke for each increment in PM2.5
The yearly trends for the average concentrations of air exposure. A variety of adjustment models controlling for
pollutants are shown in Figure S1. All measured pollutants potential confounding factors such as age, sex, and other
except O3 demonstrated consistent decreases. Daily concen- baseline cardiovascular risk factors showed consistent results.
trations of air pollutants during the study period and their The risks of cardiovascular mortality and stroke were
correlation matrix are summarized in Tables S1 and S2. The sensitive to increasing ambient NO2 exposure, whereas those
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
daily mean concentration of PM2.5 was 25.0 lg/m3. The of cardiovascular mortality and AMI were sensitive to CO. In
individual exposure to air pollutants varied: The mean PM2.5 contrast, O3 was inversely correlated with the risks of
was 25.6 lg/m3 (minimum, 23.8 lg/m3; maximum, cardiovascular events.
27.8 lg/m3).
Figure 2. Relationship between long exposure to PM2.5, PM2.5–10, CO, SO2, and NO2 and composite cardiovascular events. Cox regression
model for cardiovascular risk in response to PM2.5 exposure was smoothed using penalized spline methods with 3 df. The y-axis represents the
log hazard ratio (solid line). CO indicates carbon monoxide; NO2, nitrogen dioxide: O3, ozone; PM2.5, fine particulate matter ≤2.5 lm in
aerodynamic diameter; PM2.5–10 indicates fine particulate matter ≤2.5 to 10 lm in aerodynamic diameter; SO2, sulfur dioxide.
ORIGINAL RESEARCH
Table 2. Estimated HRs and 95% CIs for Cardiovascular Events According to Increased Exposure to Air Pollutants
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
Composite cardiovascular events 1.36 (1.29–1.43) <0.001 1.37 (1.30–1.44) <0.001 1.42 (1.33–1.51) <0.001 1.41 (1.32–1.50) <0.001
All-cause death 1.36 (1.29–1.43) <0.001 1.38 (1.31–1.45) <0.001 1.34 (1.23–1.44) <0.001 1.32 (1.22–1.43) <0.001
Cardiovascular death 1.24 (1.09–1.42) 0.0011 1.26 (1.11–1.44) <0.001 1.38 (1.13–1.68) 0.002 1.36 (1.11–1.66) 0.003
Acute myocardial infarction 1.30 (1.16–1.46) <0.001 1.33 (1.19–1.49) <0.001 1.36 (1.19–1.56) <0.001 1.36 (1.19–1.56) <0.001
Congestive heart failure 1.39 (1.28–1.52) <0.001 1.42 (1.31–1.55) <0.001 1.46 (1.31–1.62) <0.001 1.44 (1.29–1.61) <0.001
Stroke 1.34 (1.25–1.43) <0.001 1.35 (1.26–1.45) <0.001 1.40 (1.28–1.52) <0.001 1.39 (1.27–1.52) <0.001
Ischemic stroke 1.37 (1.27–1.49) <0.001 1.39 (1.28–1.51) <0.001 1.46 (1.31–1.62) <0.001 1.45 (1.31–1.61) <0.001
Hemorrhagic stroke 1.18 (1.04–1.33) 0.011 1.19 (1.05–1.35) 0.005 1.23 (1.06–1.43) 0.008 1.22 (1.05–1.42) 0.009
PM2.5–10, per 1 lg/m3
Composite cardiovascular events 2.01 (1.97–2.04) <0.001 1.76 (1.74–1.79) <0.001 1.90 (1.85–1.95) <0.001 1.91 (1.86–1.96) <0.001
All-cause death 1.99 (1.96–2.03) <0.001 1.67 (1.65–1.70) <0.001 1.69 (1.65–1.74) <0.001 1.68 (1.64–1.73) <0.001
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Cardiovascular death 1.98 (1.89–2.08) <0.001 1.62 (1.56–1.69) <0.001 1.64 (1.54–1.76) <0.001 1.63 (1.53–1.75) <0.001
Acute myocardial infarction 2.44 (2.33–2.55) <0.001 2.16 (2.07–2.25) <0.001 2.13 (2.01–2.25) <0.001 2.14 (2.02–2.27) <0.001
Congestive heart failure 1.39 (1.28–1.52) <0.001 1.42 (1.31–1.55) <0.001 1.46 (1.31–1.62) <0.001 1.44 (1.29–1.61) <0.001
Stroke 2.11 (2.07–2.16) <0.001 1.85 (1.81–1.88) <0.001 2.00 (1.94–2.06) <0.001 2.02 (1.96–2.09) <0.001
Ischemic stroke 2.12 (2.07–2.17) <0.001 1.82 (1.78–1.86) <0.001 1.98 (1.92–2.06) <0.001 2.01 (1.94–2.08) <0.001
Hemorrhagic stroke 2.57 (2.43–2.72) <0.001 2.39 (2.26–2.52) <0.001 2.42 (2.26–2.59) <0.001 2.46 (2.28–2.64) <0.001
CO, per IQR (0.25 ppm)
Composite cardiovascular events 1.92 (1.77–2.09) <0.001 1.83 (1.69–1.98) <0.001 1.79 (1.62–1.98) <0.001 1.79 (1.61–1.99) <0.001
All-cause death 1.95 (1.79–2.12) <0.001 1.83 (1.68–1.99) <0.001 1.75 (1.54–1.97) <0.001 1.72 (1.52–1.94) <0.001
Cardiovascular death 2.51 (2.02–3.13) <0.001 2.28 (1.84–2.81) <0.001 3.07 (2.20–4.29) <0.001 2.96 (2.12–4.14) <0.001
Acute myocardial infarction 2.47 (2.06–2.97) <0.001 2.32 (1.95–2.76) <0.001 2.13 (1.73–2.61) <0.001 2.12 (1.72–2.61) <0.001
Congestive heart failure 1.88 (1.64–2.16) <0.001 1.81 (1.58–2.08) <0.001 1.84 (1.55–2.19) <0.001 1.86 (1.56–2.21) <0.001
Stroke 2.08 (1.86–2.33) <0.001 1.99 (1.78–2.23) <0.001 1.98 (1.72–2.28) <0.001 2.00 (1.73–2.30) <0.001
Ischemic stroke 2.06 (1.81–2.36) <0.001 1.97 (1.73–2.24) <0.001 1.88 (1.60–2.22) <0.001 1.91 (1.62–2.25) <0.001
Hemorrhagic stroke 2.04 (1.66–2.50) <0.001 1.99 (1.62–2.43) <0.001 2.22 (1.73–2.86) <0.001 2.22 (1.73–2.87) <0.001
SO2, per IQR (2.54 ppb)
Composite cardiovascular events 2.06 (1.93–2.20) <0.001 1.97 (1.84–2.10) <0.001 1.99 (1.83–2.17) <0.001 1.94 (1.78–2.11) <0.001
All-cause death 1.97 (1.83–2.11) <0.001 1.84 (1.72–1.97) <0.001 1.73 (1.56–1.93) <0.001 1.73 (1.55–1.92) <0.001
Cardiovascular death 2.02 (1.69–2.41) <0.001 1.83 (1.55–2.17) <0.001 1.48 (1.13–1.93) 0.004 1.50 (1.14–1.96) 0.00316
Acute myocardial infarction 1.81 (1.55–2.11) <0.001 1.75 (1.51–2.04) <0.001 1.83 (1.52–2.20) <0.001 1.82 (1.52–2.19) <0.001
Congestive heart failure 2.02 (1.80–2.26) <0.001 1.95 (1.74–2.18) <0.001 2.00 (1.73–2.31) <0.001 2.00 (1.73–2.32) <0.001
Stroke 2.25 (2.05–2.48) <0.001 2.17 (1.97–2.38) <0.001 2.25 (2.00–2.53) <0.001 2.25 (2.00–2.54) <0.001
Ischemic stroke 2.31 (2.07–2.58) <0.001 2.20 (1.98–2.45) <0.001 2.32 (2.02–2.66) <0.001 2.33 (2.02–2.68) <0.001
Hemorrhagic stroke 2.24 (1.89–2.66) <0.001 2.19 (1.86–2.60) <0.001 2.13 (1.73–2.62) <0.001 2.13 (1.73–2.62) <0.001
NO2, per IQR (18.4 ppb)
Composite cardiovascular events 2.17 (2.01–2.34) <0.001 2.06 (1.91–2.22) <0.001 2.30 (2.08–2.55) <0.001 2.30 (2.08–2.55) <0.001
All-cause death 2.05 (1.89–2.22) <0.001 1.91 (1.76–2.07) <0.001 1.80 (1.60–2.04) <0.001 1.79 (1.59–2.03) <0.001
Cardiovascular death 2.79 (2.26–3.45) <0.001 2.47 (2.01–3.03) <0.001 2.70 (1.96–3.72) <0.001 2.67 (1.94–3.69) <0.001
Continued
ORIGINAL RESEARCH
Table 2. Continued
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
Acute myocardial infarction 1.73 (1.45–2.06) <0.001 1.68 (1.41–2.00) <0.001 1.81 (1.46–2.25) <0.001 1.81 (1.46–2.25) <0.001
Congestive heart failure 2.12 (1.86–2.43) <0.001 2.05 (1.79–2.33) <0.001 2.40 (2.02–2.86) <0.001 2.40 (2.02–2.85) <0.001
Stroke 2.32 (2.07–2.59) <0.001 2.24 (2.01–2.50) <0.001 2.64 (2.29–3.05) <0.001 2.65 (2.29–3.06) <0.001
Ischemic stroke 2.48 (2.17–2.82) <0.001 2.37 (2.09–2.70) <0.001 2.73 (2.30–3.24) <0.001 2.74 (2.31–3.24) <0.001
Hemorrhagic stroke 2.02 (1.66–2.46) <0.001 2.00 (1.64–2.43) <0.001 2.43 (1.90–3.11) <0.001 2.43 (1.90–3.12) <0.001
O3, per IQR (15.9 ppb)
Composite cardiovascular events 0.65 (0.62–0.68) <0.001 0.67 (0.64–0.70) <0.001 0.63 (0.59–0.67) <0.001 0.63 (0.63–0.73) <0.001
All-cause death 0.66 (0.63–0.69) <0.001 0.69 (0.65–0.72) <0.001 0.68 (0.63–0.73) <0.001 0.68 (0.63–0.73) <0.001
Cardiovascular death 0.58 (0.52–0.66) <0.001 0.62 (0.55–0.70) <0.001 0.59 (0.49–0.71) <0.001 0.59 (0.49–0.71) <0.001
Acute myocardial infarction 0.73 (0.65–0.81) <0.001 0.74 (0.67–0.83) <0.001 0.72 (0.63–0.82) <0.001 0.71 (0.63–0.82) <0.001
Congestive heart failure 0.69 (0.63–0.74) <0.001 0.70 (0.65–0.76) <0.001 0.64 (0.58–0.71) <0.001 0.64 (0.58–0.71) <0.001
Stroke 0.63 (0.59–0.67) <0.001 0.64 (0.60–0.69) <0.001 0.60 (0.55–0.65) <0.001 0.60 (0.55–0.65) <0.001
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Ischemic stroke 0.62 (0.57–0.66) <0.001 0.63 (0.59–0.68) <0.001 0.60 (0.54–0.66) <0.001 0.60 (0.54–0.66) <0.001
Hemorrhagic stroke 0.69 (0.62–0.78) <0.001 0.70 (0.62–0.79) <0.001 0.62 (0.53–0.71) <0.001 0.62 (0.53–0.71) <0.001
CI indicates confidence interval; CO, carbon monoxide; HR, hazard ratio; IQR, interquartile range; NO2, nitrogen dioxide: O3, ozone; PM2.5, fine particulate matter ≤2.5 lm in aerodynamic
diameter; PM2.5–10 indicates fine particulate matter ≤2.5 to 10 lm in aerodynamic diameter; ppm, parts per million, 10 6; ppb, parts per billion, 10 9; SO2, sulfur dioxide.
*Multivariable-adjusted model 1 was adjusted for age, sex, socioeconomic status, hypertension, diabetes mellitus, dyslipidemia, chronic renal failure, end-stage renal diseases, ischemic
heart disease, peripheral arterial disease, chronic obstructive pulmonary disease, and malignancy.
†
Multivariable-adjusted model 2 was adjusted for the variables listed above as well as body mass index, fasting blood glucose, total cholesterol, and hemoglobin. Composite cardiovascular
events were a composite of cardiovascular death, acute myocardial infarction, congestive heart failure, and stroke.
10, CO, SO2, NO2, or O3. In addition, the effects of other air PM2.5 was associated with a 36% increase in cardiovascular
pollutants with multipollutant models were also similar with risks including mortality, AMI, CHF, and stroke. Other
those of single-pollutant models. pollutants such as PM2.5–10, CO, SO2, and NO2 also had an
The cardiovascular risks associated with PM2.5 exposure adverse impact on cardiovascular events. This study also
did not differ significantly across various subgroups (Fig- demonstrated that the burden from air pollution was as large
ure 4). No significant interactions were observed with regard as that of conventional cardiovascular risk factors such as
to sex, age, presence of cardiovascular risk factors, anemia, hypertension and diabetes mellitus in this study population.
and malignancy. Particulate matter is a mixture of solid particles and liquid
Long-term exposure to a PM2.5 concentration >25 lg/ droplets suspended in the air. The size of particles is directly
m —the mean daily concentration in Seoul during the study
3
linked to their impact on human health.16 PM2.5, also known
period—was responsible for 30.8% of the population-attribu- as fine particles, has a small diameter that enables particles
table risks for composite cardiovascular events (Table 3). to reach deep into the lungs and penetrate the alveolar–
Population-attributable risks were 23.7% for men and 39.0% capillary epithelium.17 Evidence suggests the effects are
for women. The burden attributable to air pollution was stronger for cardiovascular mortality than for other causes of
comparable to or greater than those from conventional major mortality.17–19 Although most previous studies on the long-
cardiovascular risk factors such as hypertension, diabetes term effects evaluated mortality risks, the major novel finding
mellitus, dyslipidemia, and obesity. of this study is the association of air pollution with specific
major cardiovascular diseases.
The potential biological mechanisms explaining the asso-
Discussion ciation between air pollution and cardiovascular diseases
We performed a large-scale population-based study evaluating include systemic inflammation caused by oxidative stress,
the cardiovascular impact of long-term exposure to air autonomic imbalance, and the possible direct actions of
pollution. In this study, we found that long-term exposure to pollutants reaching the systemic circulation.4,5 Acceleration
high levels of air pollution was associated with increased risk of atherosclerosis and vascular inflammation in response to
of major adverse cardiovascular events as well as all-cause long-term air pollution exposure was suggested in an animal
deaths. Every 1-lg/m3 increase of long-term exposure to model.20 Recently, studies from the MESA Air (Multi-Ethnic
ORIGINAL RESEARCH
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Figure 3. Kaplan–Meier survival curves for composite cardiovascular events in response to long-term
exposure to ambient PM2.5. PM2.5 indicates fine particulate matter ≤2.5 lm in aerodynamic diameter.
Study of Atherosclerosis and Air Pollution) cohort have 1.5 lg/m3. Although Seoul has a large area of 605.21 km2, it
demonstrated that long-term PM2.5 concentrations are asso- is also one of the most densely populated cities worldwide.30
ciated with the progression of intima–media thickness on Fourth, there may be ethnic differences between study
ultrasound examination and coronary calcification measured populations. Finally, although we performed rigorous adjust-
by cardiac computed tomography.21,22 In addition, greater ment for baseline cardiovascular risk factors, there could be
reductions in PM2.5 were related to slower progression of unaccounted-for potential confounders.
intima–medial thickness progression. In the present study, we This study is the first investigation performed in the Asia–
found that the impact of air pollution is not confined to Pacific region regarding the long-term effects of air pollution.
atherosclerotic cardiovascular diseases such AMI and According to the Global Burden of Disease Study 2015, the
ischemic stroke but also affects CHF and hemorrhagic stroke. mean PM2.5 is 58.4 and 28.7 lg/m³ in China and South
The estimated risk of air pollution shown in the present Korea, respectively.2 A report from the Environmental Perfor-
study was larger than the risk reported in previous studies mance Index estimated that >50% of the populations of these
from the United States and Europe.23–26 There may be several countries are exposed to unsafe levels of fine particulate
explanations for this difference. First, the level of air pollution matter.31 A recent study found that 17% of all deaths in
in Seoul is higher than that in Western countries. The China are attributable to air pollution.32 This study adds to the
individual weighted mean concentration of PM2.5 was current evidence that the cardiovascular burden of air
25.0 lg/m3 among the present study participants, who pollution should be considered as important as conventional
resided in Seoul between 2007 and 2013, whereas it is cardiovascular risk factors.
typically <15 lg/m³ in Western countries.6,27 The impact of This study has several limitations. First, we estimated
ambient PM2.5 may differ with varying degrees of baseline individual exposure to air pollution using the ambient
PM2.5 levels. Second, the composition and sources of the concentrations measured by outdoor monitors. People who
particles differ between East Asia and Western countries. live in industrialized countries spend 90% of their time
Recent studies suggest that specific PM constituents play a indoors.33 A growing body of evidence indicates that exposure
more important role than the total mass concentration.28 This to air pollution indoors also has health impacts. Second, we
geographic region is under rapid industrialization, and a large linked the ZIP code of each study participant’s residence to
proportion of air pollution is suggested to be associated with the location of the monitoring stations; however, many people
fossil fuel combustion.29 Third, individual PM2.5 concentra- may spend much of their time at their workplace, which may
tions fell within a narrow range with an interquartile range of be far from their home. Conversely, using administrative data
ORIGINAL RESEARCH
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Figure 4. Subgroup analysis for cardiovascular risk of long-term exposure to PM2.5. The x-axis represents hazard ratios with 95% confidence
intervals. Int P denotes interaction P value; PM2.5 indicates fine particulate matter ≤2.5 lm in aerodynamic diameter.
ensures reliable information on the individual residence with Misclassification is a potential cause of bias in population-
freedom from recall or nonresponse bias. Third, although based studies using claims records.34
PM2.5 is a heterogeneous mixture of solid and liquid particles In conclusion, this study revealed that long-term exposure
emitted from a variety of sources, we could not estimate the to air pollution increases the risk of major cardiovascular
specific constituents and sources of the particles. Fourth, we diseases such AMI, CHF, stroke, and mortality. Air pollutants
used claims data to define covariates and outcomes. including PM2.5, PM2.5–10, CO, SO2, and NO2, but not O3,
Table 3. Population Attributable Risk Percentages and 95% CIs Associated With Selected Cardiovascular Risk Factors for
Composite Cardiovascular Outcomes
Sex Age
CI indicates confidence interval; PM2.5, fine particulate matter ≤2.5 lm in aerodynamic diameter.
ORIGINAL RESEARCH
demonstrated positive relationships with cardiovascular risks, 15. Crowson CS, Therneau TM, O’Fallon WM. Attributable risk estimation in cohort
studies 2009. Available at: http://www.mayo.edu/research/documents/
and the effects were consistent after adjusting for baseline biostat-82pdf/doc-10027843. Accessed June 22, 2017.
risk factors and other pollutants. The attributable risk from air 16. United States Environmental Protection Agency. Particulate matter (PM)
basics. 2017.
pollution was as large as that of conventional cardiovascular
17. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung
risk factors such as hypertension and diabetes mellitus. cancer, cardiopulmonary mortality, and long-term exposure to fine particulate
air pollution. JAMA. 2002;287:1132–1141.
18. Martin LD, Krunkosky TM, Dye JA, Fischer BM, Jiang NF, Rochelle LG, Akley NJ,
Dreher KL, Adler KB. The role of reactive oxygen and nitrogen species in the
Disclosures response of airway epithelium to particulates. Environ Health Perspect.
1997;105(suppl 5):1301–1307.
None.
19. Dockery DW, Stone PH. Cardiovascular risks from fine particulate air pollution.
N Engl J Med. 2007;356:511–513.
20. Nemmar A, Hoylaerts MF, Nemery B. Effects of particulate air pollution on
References hemostasis. Clin Occup Environ Med. 2006;5:865–881.
1. World Health Organization. Burden of disease from household air pollution for 21. Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, Budoff M,
2012. 2012. Jacobs DR Jr, Barr RG, Watson K, Kaufman JD. Fine particulate air pollution and
2. Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Balakrishnan the progression of carotid intima-medial thickness: a prospective cohort study
from the Multi-Ethnic Study of Atherosclerosis and air pollution. PLoS Med.
K, Brunekreef B, Dandona L, Dandona R, Feigin V, Freedman G, Hubbell B,
2013;10:e1001430.
Jobling A, Kan H, Knibbs L, Liu Y, Martin R, Morawska L, Pope CA III, Shin H,
Straif K, Shaddick G, Thomas M, van Dingenen R, van Donkelaar A, Vos T, 22. Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, Daviglus ML, Diez
Murray CJ, Forouzanfar MH. Estimates and 25-year trends of the global burden Roux AV, Gassett AJ, Jacobs DR Jr, Kronmal R, Larson TV, Navas-Acien A,
of disease attributable to ambient air pollution: an analysis of data from the Olives C, Sampson PD, Sheppard L, Siscovick DS, Stein JH, Szpiro AA, Watson
Global Burden of Diseases Study 2015. Lancet. 2017;389:1907–1918. KE. Association between air pollution and coronary artery calcification within
six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis
3. Global Burden of Disease 2015 Risk Factors Collaborators. Global, regional,
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Quantiles
Pollutants Mean (SD*) IQR†
Min‡ 25% 50% 75% Max§
PM2.5, μg/m3 25.03 (14.29) 2.79 15.04 21.92 31.00 121.10 15.96
PM2.5-10, μg/m3 25.23 (20.99) 2.00 13.52 21.21 30.04 367.30 16.52
CO, ppm|| 0.57 (0.24) 0.19 0.41 0.51 0.66 1.81 0.25
SO2, ppb# 5.53 (2.30) 2.24 9.92 4.92 6.46 22.52 2.54
NO2, ppb 34.45 (12.92) 6.44 24.52 32.32 42.92 92.35 18.4
O3, ppb 19.93 (10.86) 1.84 11.18 18.75 27.08 71.12 15.9
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
*SD denotes standard deviation; †IQR, interquartile ranges; ‡min, minimum; §max,
Sex
Event Total
Male Female
Major adverse cardiovascular events 1,856 (0.21)* 1001 (0.23) 855 (0.19)
exposure to PM2.5. The y-axis denotes the hazard ratio (box) with 95% confidence intervals
(line).
Downloaded from http://jaha.ahajournals.org/ by guest on April 3, 2018
Cardiovascular Effects of Long−Term Exposure to Air Pollution: A Population−Based Study
With 900 845 Person−Years of Follow−up
Hyeanji Kim, Joonghee Kim, Sunhwa Kim, Si-Hyuck Kang, Hee-Jun Kim, Ho Kim, Jongbae Heo,
Seung-Muk Yi, Kyuseok Kim, Tae-Jin Youn and In-Ho Chae
doi: 10.1161/JAHA.117.007170
The Journal of the American Heart Association is published by the American Heart Association, 7272 Greenville Avenue,
Dallas, TX 75231
Online ISSN: 2047-9980
The online version of this article, along with updated information and services, is located on the
World Wide Web at:
http://jaha.ahajournals.org/content/6/11/e007170
Subscriptions, Permissions, and Reprints: The Journal of the American Heart Association is an online only Open
Access publication. Visit the Journal at http://jaha.ahajournals.org for more information.